Actively Recruiting
Multi-Center Registry Cohort Study on Prognostic Factors and Prediction Model Construction in Aneurysmal SAH
Led by Second Affiliated Hospital of Nanchang University · Updated on 2026-04-30
5000
Participants Needed
1
Research Sites
586 weeks
Total Duration
On this page
Sponsors
S
Second Affiliated Hospital of Nanchang University
Lead Sponsor
P
Panzhihua Central Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
PROSAH-MPC, a collaborative research project among neurosurgical centers in China, focuses on aneurysmal subarachnoid hemorrhage (aSAH). Its aim is to identify prognostic factors and develop robust prediction models for complications, disability, and mortality in aSAH patients. By leveraging a large, multi-center, prospective cohort design, PROSAH-MPC aims to overcome limitations of past studies and provide a more comprehensive understanding of the disease.
CONDITIONS
Official Title
Multi-Center Registry Cohort Study on Prognostic Factors and Prediction Model Construction in Aneurysmal SAH
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Subarachnoid hemorrhage confirmed by computed tomography (CT)
- Cerebral angiography (CTA) and digital subtraction angiography (DSA) confirming intracranial aneurysm rupture as cause of hemorrhage
- Blood routine, biochemical function, blood coagulation, and craniocerebral CT done within 24 hours of symptom onset
- Underwent aneurysm clipping surgery or endovascular embolization within 72 hours after onset
You will not qualify if you...
- Aneurysm rupture bleeding time exceeding 24 hours before hospital admission
- Incomplete imaging data or blood test information
- Long-term use of anticoagulant medications such as aspirin or warfarin
- Admitted with active infectious diseases
- Presence of other intracranial vascular malformations
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The Second Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China, 330006
Actively Recruiting
Research Team
X
Xingen Zhu, Prof
CONTACT
P
Ping Hu, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here